Lilly Global Giving Puts Power of Philanthropy in Employees' Hands

Eli Lilly and CompanyFor the first time, Eli Lilly and Company (NYSE: LLY) employees worldwide can donate to more than 800 grassroots projects across the globe and have their donations matched by the Eli Lilly and Company Foundation - doubling the value and impact of each employee's charitable contribution.

Lilly is partnering with the GlobalGiving Foundation to offer its employees across the world a customized Lilly Global Giving website, where employees may choose from multiple projects that are helping to advance Lilly's corporate responsibility goals in the areas of health, hunger, education, and the environment.

Employees who donate $25 (USD) or more to projects featured on the Lilly Global Giving website will have their donations automatically matched by the Lilly Foundation. Each year, the Lilly Foundation will match employees' contributions through the program up to $1 million (USD) companywide.

To encourage employees' participation in the new program, the Lilly Foundation is offering every eligible Lilly employee worldwide the opportunity to direct a $50 (USD) credit toward causes that are most meaningful to them via the Lilly Global Giving website. For each project to which they donate, employees will receive updates from project leaders to learn how their contributions are making a difference in the lives of others.

"We have a 135-year history of giving back and are proud of the Lilly Foundation's strong philanthropic footprint in Indianapolis and across the United States," said John C. Lechleiter, Ph.D., Lilly chairman, president, and chief executive officer. "Through Lilly Global Giving, we're expanding our reach and engaging our employees in new ways. For the first time, Lilly employees worldwide will have the opportunity to support global projects they're passionate about and have their contributions matched by the Lilly Foundation. Not only does the match make their donations go twice as far, it gives our employees a voice in how we use some of the Lilly Foundation's resources."

Lechleiter noted that the new Lilly Global Giving program complements the Lilly Foundation's U.S. matching gifts program, which allows U.S. employees to have donations matched for select non-profit organizations, such as the United Way.

"Our company is global and so is our role as a good corporate citizen," Lechleiter added. "Lilly Global Giving is a natural extension of our corporate responsibility efforts and our vision to make a significant contribution to humanity by improving global health in the 21st century."

Through Lilly Global Giving, employees may support hundreds of different grassroots programs, including projects that:

  • provide insulin and insulin supplies to patients in Guatemala;
  • improve the diagnosis and care of people with tuberculosis in India;
  • teach farmers in Zambia about animal management and sustainable farming;
  • provide an education for orphaned children in Cameroon; and
  • help restore acres of rainforest in Brazil, among hundreds of other projects.

By participating in Lilly Global Giving, employees may select, contribute to, and follow the progress of global programs that are addressing causes they care about.

Lilly selected the GlobalGiving Foundation as its partner because of the organization's grassroots approach, which connects donors to charitable projects and puts decision-making in donors' hands. Projects approved by the GlobalGiving Foundation have undergone compliance checks to ensure they meet applicable laws relating to international philanthropy. Since 2002, the GlobalGiving Foundation has channeled more than $44 million in donations to eligible projects and programs across the globe.

"We are so excited to work with Lilly to provide a unique way for its employees to support high-quality projects around the world," said Donna Callejon, GlobalGiving's chief business officer. "Lilly employees have a long history of generosity, and we are glad to help them extend that generosity even further."

Lilly Corporate Responsibility
Lilly Global Giving expands the global reach of Lilly's corporate responsibility efforts, which are focused on:

  • improving health for people in need, especially in low- and middle-income countries;
  • improving specifically K-12 education in the company's home state of Indiana;
  • improving communities that are home to Lilly's major operations;
  • fostering a healthier environment, specifically in areas that are touched by its operations.

Lilly Global Giving provides employees with unique opportunities to help advance this work and gain a deeper understanding of the challenges faced by people and communities across the world.

Earlier this year, Lilly introduced its Connecting Hearts Abroad program. In 2011, 200 employees will travel to 10 countries to assist people and communities that often lack access to basic resources. To date, 70 Lilly Ambassadors with Connecting Hearts Abroad have completed two-week global service assignments in Brazil, China, Ghana, Guatemala, India, Russia, Tanzania, and Thailand.

In addition, Lilly employees worldwide are gearing up for the fourth annual Lilly Global Day of Service on October 6, 2011. The annual employee service event has been recognized as one of the largest, single-day volunteer initiatives of any company in the U.S.

About the GlobalGiving Foundation
The GlobalGiving Foundation helps individual and corporate donors contribute directly to grassroots charitable organizations around the world. Utilizing their network of local projects and web-based platform, globalgiving.org, GlobalGiving helps companies achieve their charitable, corporate responsibility, employee engagement, and cause-marketing goals. GlobalGiving finds and vets projects, disburses funds, ensures reporting and develops web solutions that leverage their community for corporate partner programs. GlobalGiving is a 501c(3) registered nonprofit organization, located in Washington, D.C.

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

Most Popular Now

Scientists uncover SARS-CoV-2-specific T cell immu…

The study by scientists from Duke-NUS Medical School, in close collaboration with the National University of Singapore (NUS) Yong Loo Lin School of Medicine, Singapore Ge...

Common FDA-approved drug may effectively neutraliz…

A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in ...

Neutralizing antibodies isolated from COVID-19 pat…

Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing ...

Another mRNA-based vaccine candidate protects anim…

An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and no...

GSK and CureVac announce strategic mRNA technology…

GlaxoSmithKline plc (LSE/NYSE: GSK) and CureVac announced the signing of a strategic collaboration agreement for the research, development, manufacturing and commercialis...

Pfizer and BioNTech granted FDA Fast Track designa…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced that two of the companies' four investigational vaccine candidates from their BNT162 mRNA-bas...

Novartis launches first-of-its-kind not-for-profit…

Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms o...

COVID-19 vaccine AZD1222 showed robust immune resp…

Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and generated robust immune responses against the SARS-Co...

Pfizer and BioNTech announce an agreement with U.S…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of...

Pfizer and BioNTech choose lead mRNA vaccine candi…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study to evaluate a singl...

Experimental COVID-19 vaccine protects upper and l…

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper an...

Pfizer and BioNTech announce agreement with the Un…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced an agreement with the United Kingdom to supply 30 million doses of their BNT162 mRNA-based vaccine candid...